The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.
Dubai declares remote work for government employees
UAE issues federal decree-law establishing National Media Authority
More rain forecast in Dubai for late Thursday, says NCM
UAE leaders laud 'deep-rooted partnership' on Qatar's National Day
Dubai authorities urge caution amid unstable weather
UAE steps up Gaza relief efforts as winter storm intensifies
UAE, Azerbaijan Presidents strengthen bilateral cooperation
UAE announces new cut-off age for KG, Grade 1 school admissions
Dubai Police recognised as world’s most agile police force
UAE honours Professor Majed Chergui with 'Great Arab Minds' award
UAE issues yellow alert as dusty conditions reduce visibility
Traffic diversions in Ras Al Khor for Dubai Metro Blue Line works
UAE set for second phase of single-use plastic ban
Minor earthquake recorded east of Saudi Arabia
World’s Coolest Winter campaign spotlights UAE entrepreneurs
H.H. Sheikh Hamdan highlights social cohesion in 'Dubai Lunch' initiative
Dubai tests drones to clean traffic signals
UAE leaders hail 'enduring bonds of friendship' on Bahrain's National Day
UAE locally produces 3 oncology medicines to strengthen fight against cancer
